Tag: Multiple

Inflammation protection may be critical to treating multiple sclerosis

Prolonging a cellular defense response to inflammation could help regenerate the protective coating of axons that is degraded in diseases such as multiple sclerosis (MS), according to a Northwestern Medicine study published in eLife. There are currently no FDA-approved drugs that have been shown to effectively regenerate this coating, called myelin. This new strategy could

Gut bacteria in multiple sclerosis: Probiotic or commensal, good or bad?

Researchers from the University of Vermont (UVM) have found that a bacterial species called Lactobacillus reuteri, commonly used in probiotics, can increase disease severity in a mouse model of multiple sclerosis (MS), an autoimmune disease that is the leading cause of non-traumatic neurological disability in young adults. But don’t throw away your yogurt just yet.

New discovery provides hope for improved multiple sclerosis therapies

Scientists from Trinity College Dublin have made an important discovery that could lead to more effective treatments for people living with multiple sclerosis (MS) and other autoimmune diseases such as psoriasis and rheumatoid arthritis. Their work highlights the significant potential of drugs targeting a specific immune molecule (IL-17) implicated in MS. The scientists, led by

A new culprit for multiple sclerosis relapses

A molecule that helps blood clot may also play a role in multiple sclerosis relapses, researchers report in the May 6 issue of PNAS. The new research may help answer the mystery of why remissions happen, as well as find early markers of the disease. The research also shows a new way to study multiple

Yes, You Really Can Achieve Multiple Orgasms

For some women, having multiple orgasms is the sexual Mount Everest of pleasure. However, Stella Harris, Intimacy Educator, Sex Coach, and author of Tongue Tied: Untangling Communication in Sex, Kink, and Relationships, tells SheKnows that multiple orgasms can be a bit of a misnomer. “The orgasms don’t necessarily happen one right after the other,” she

Early intensive therapy for multiple sclerosis leads to better long-term outcomes, despite being perceived as high risk

New findings by researchers at Cardiff University suggest that intensive therapy during the early stages of multiple sclerosis (MS) leads to better long-term outcomes for patients, despite it often being viewed as a riskier option than other first line treatments. Dr. Emma Tallantyre, from Cardiff University’s Division of Psychological Medicine and Clinical Neurosciences, said: “Over

Effects of teenage motherhood may last multiple generations

The grandchildren of adolescent mothers have lower school readiness scores than their peers, according to a study published February 6, 2019 in the open-access journal PLOS ONE by Elizabeth Wall-Wieler of Stanford University and colleagues at the University of Manitoba. Previous studies have established that children born to adolescent mothers are less ready for school

Environmental factors may trigger onset of multiple sclerosis

A new Tel Aviv University study finds that certain environmental conditions may precipitate structural changes that take place in myelin sheaths in the onset of multiple sclerosis (MS). Myelin sheaths are the “insulating tape” surrounding axons; axons carry electrical impulses in neurons. The research demonstrates that myelin sheaths undergo structural transitions when triggered by changes

Multiple Pathways Explain Age-Linked Increase in Dementia Risk

MONDAY, Sept. 24, 2018 — Multiple pathways account for the age-related increases in dementia risk, according to a study recently published in the Annals of Neurology. Melinda C. Power, Sc.D., from the George Washington University Milken Institute School of Public Health in Washington, D.C., and colleagues used data from 1,362 autopsied participants of three community-based

£19,000-a-year MS drug is ‘too expensive for the NHS’

Thousands will be denied £19,000-a-year drug for multiple sclerosis Thousands will be denied £19,000-a-year drug for multiple sclerosis which could keep them out of a wheelchair because it’s too expensive for the NHS Ocrelizumab is the first-ever drug to effectively treat primary progressive MS But NHS rationing watchdog NICE said £9,600 price rag did not